DR. GILAD SHALAG GORDON, MD
Osteopathic Medicine at Rockmont Cir, Boulder, CO

License number
Colorado 26496
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
1565 Rockmont Cir, Boulder, CO 80305
Phone
(303) 517-6212
(303) 494-4103 (Fax)

Personal information

See more information about GILAD SHALAG GORDON at radaris.com
Name
Address
Phone
Gilad Gordon, age 67
1565 Rockmont Cir, Boulder, CO 80305
(303) 494-4102
Gilad Gordon
Denver, CO
(303) 494-4102
Gilad Gordon
Vail, CO
(970) 949-5714
Gilad Gordon
105 Columbine Cir, Avon, CO 81620
(970) 748-8906
(970) 949-5714
Gilad S Gordon, age 67
1565 Rockmont Cir, Boulder, CO 80305
(303) 494-4102

Professional information

Gilad Gordon Photo 1

Board Of Directors Member At Caring For Colorado

Position:
Chief Medical Officer at Inviragen, Inc., Advisory board member at Georgetown Lombardi Comprehensive Cancer Center, Board of Directors member at Caring for Colorado, President at ORRA Group, LLC
Location:
Greater Denver Area
Industry:
Biotechnology
Work:
Inviragen, Inc. - Ft. Collins, CO since Jan 2011 - Chief Medical Officer Georgetown Lombardi Comprehensive Cancer Center since 2009 - Advisory board member Caring for Colorado - Denver, CO since May 2008 - Board of Directors member ORRA Group, LLC since May 2004 - President QLT Inc. 2005 - 2012 - Consultant Array BioPharma 2004 - 2011 - consultant OSI Pharmaceuticals - Boulder, CO 2004 - 2010 - Consultant Attenuon, LLC 2006 - 2008 - Consulting CMO
Education:
University of Washington 1986 - 1988
Master of Business Administration (MBA), Finance, General
Harvard Medical School 1979 - 1983
Doctor of Medicine (MD)
Harvard College 1975 - 1979
AB, Biochemistry


Gilad S Gordon Photo 2

Dr. Gilad S Gordon, Boulder CO - MD (Doctor of Medicine)

Address:
1565 Rockmont Cir, Boulder 80305
(303) 517-6212 (Phone), (303) 494-4103 (Fax)
1565 Rockmont Cir, Boulder 80305
(303) 517-6212 (Phone), (303) 494-4103 (Fax)
Education:
Medical Schools
Harvard Medical School
Graduated: 1983


Gilad Gordon Photo 3

Method And Reagent For The Modulation Of Female Reproductive Diseases And Conditions

US Patent:
2003021, Nov 20, 2003
Filed:
Nov 27, 2002
Appl. No.:
10/306747
Inventors:
Jennifer Lockridge - Westminster CO, US
Pamela Pavco - Lafayette CO, US
Gilad Gordon - Boulder CO, US
International Classification:
A61K048/00
US Classification:
514/044000
Abstract:
The present invention relates to nucleic acid molecules, including dsRNA, siRNA, antisense, 2,5-A chimeras, aptamers, and enzymatic nucleic acid molecules, such as hammerhead ribozymes, DNAzymes, and allozymes, which modulate the expression of vascular endothelial growth factor receptor (VEGF) and/or vascular endothelial growth factor receptor (VEGFr) genes for the treatment and/or diagnosis of female reproductive disorders and conditions, including but not limited to endometriosis, endometrial carcinoma, gynecologic bleeding disorders, irregular menstrual cycles, ovulation, premenstrual syndrome (PMS), and menopausal dysfunction.